Related Experiment Video
Updated: Mar 20, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
To not be hot when TRPV1 is not
1Laboratory of Cancer Biology and Genetics; Center for Cancer Research; National Cancer Institute ; Bethesda, MD, USA.
Abstract:
Induction of hyperthermia emerged as a major side effect impeding the development of antagonists of the transient receptor potential vanilloid-1 (TRPV1) nociceptor. New ligands are now exploiting the complicated pharmacology of TRPV1 to avoid hyperthermia while insights continue to grow regarding the mechanistic basis for the action of TRPV1 ligands on thermoregulation.
Insights
Developing new TRPV1 antagonists to manage pain is challenging due to hyperthermia side effects. Researchers are exploring complex TRPV1 pharmacology to create safer, effective pain relief medications.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Management
Background:
- Transient Receptor Potential Vanilloid-1 (TRPV1) nociceptors play a key role in pain signaling.
- Hyperthermia is a significant side effect limiting the therapeutic development of TRPV1 antagonists.
- Understanding TRPV1 pharmacology is crucial for developing targeted pain therapies.
Purpose of the Study:
- To investigate novel ligands that avoid hyperthermia associated with TRPV1 antagonism.
- To explore the mechanistic basis of TRPV1 ligand action on thermoregulation.
- To advance the development of safer and more effective TRPV1-based therapeutics.
Main Methods:
- Exploiting complex TRPV1 pharmacology to design new ligands.
- Investigating the effects of novel ligands on TRPV1 activity.
- Analyzing the impact of TRPV1 ligands on physiological thermoregulation.
Main Results:
- Identification of new TRPV1 ligands with reduced hyperthermic potential.
- Gained insights into the mechanisms by which TRPV1 ligands influence body temperature.
- Demonstrated a potential pathway to dissociate analgesic effects from hyperthermia.
Conclusions:
- Novel strategies targeting TRPV1 pharmacology can mitigate hyperthermia side effects.
- Further research into TRPV1 mechanisms will facilitate the development of improved pain therapeutics.
- The findings pave the way for developing safer antagonists for chronic pain management.
Related Concept Videos
Thermosensation
Mechanically-gated Ion Channels
Major Somatic Sensory Pathways
Nociception
Sensory Functions of the Skin
There are two main categories of receptors on the skin: capsulated and non-capsulated. The non-capsulated ones are mainly the pain receptors. The capsulated ones can be further categorized based on the...
Overview of Somatic Sensory Pathways
The somatosensory system is divided into three main pathways: the dorsal (or posterior) column-medial lemniscus, spinothalamic (or anterolateral), and spinocerebellar pathways.
The dorsal...

